Saturday, April 18, 2015 1:25:38 AM
The company intends to be breakeven at q2-3 2016.
If fully diluted, the company will have 75 million shares Max.
Compared to last quarterly sales and the market cap adjusted to 70 million shares, the market cap (at 70 m shares) would equal the revenues of 3 quarters. That is still way undervalued!
Please note the following:
1. Quarterly revenues are growing significantly quarter after quarter
2. The company did cut costs by restructuring in personnel, which would equal a cut in yearly costs by 6 million dollar.
3. FDA decision is coming in May. If you looked at the last company presentation, the company believes Europe will bring 20% and the US will bring 80% of revenues.
Therefore it is my opinion that the company will be at their IPO share price of $4/share by by 2017 or sooner and be above $1 by the end of May.
If fully diluted, the company will have 75 million shares Max.
Compared to last quarterly sales and the market cap adjusted to 70 million shares, the market cap (at 70 m shares) would equal the revenues of 3 quarters. That is still way undervalued!
Please note the following:
1. Quarterly revenues are growing significantly quarter after quarter
2. The company did cut costs by restructuring in personnel, which would equal a cut in yearly costs by 6 million dollar.
3. FDA decision is coming in May. If you looked at the last company presentation, the company believes Europe will bring 20% and the US will bring 80% of revenues.
Therefore it is my opinion that the company will be at their IPO share price of $4/share by by 2017 or sooner and be above $1 by the end of May.
Recent SINT News
- SINTX Technologies to Present at the LD Micro Invitational XVI Conference • Newsfile • 05/17/2026 07:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2026 12:30:10 PM
- SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution • GlobeNewswire Inc. • 03/23/2026 01:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/20/2026 09:00:53 PM
- SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant • GlobeNewswire Inc. • 03/19/2026 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 01:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:35:38 PM
- SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms • GlobeNewswire Inc. • 02/18/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:45:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:44:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:43:48 AM
- SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 • GlobeNewswire Inc. • 01/29/2026 02:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/12/2025 05:15:20 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/09/2025 10:01:07 PM
- Sidoti Events, LLC's Year-End Virtual Investor Conference • ACCESS Newswire • 12/09/2025 05:48:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 01:00:05 PM
- SINTX Technologies to Participate in Sidoti & Company Investor Conference • GlobeNewswire Inc. • 12/08/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2025 01:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:35:26 PM
- SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
